Latvia - Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Latvia Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale grew 26.8% year on year. With €21,615,756.01 in 2019, the country was number 24 among other countries in Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Latvia is overtaken by Croatia, which was ranked number 23 with €24,738,653.77 and is followed by Malta at €5,841,633.29. France lead the ranking with €4,561,958,734.8 in 2019, +2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Malta witnessed the best average annual growth at +35.2% per year, while Finland recorded the worst performance at -24.5% per year.

Loading...

Date Euros
2019 21,615,756.01
2018 21,234,020.00
2017 17,642,140.00
2016 15,153,960.00
2015 8,746,520.00
Download all data from 2001 to 2019

How does Latvia rank in Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 27 Countries Euros Last YoY 5‑years CAGR
1 #1
France
4,561,958,734.80 2019 +2.9 % +15.9 % View data
2 #2
Belgium
3,690,243,246.91 2019 +3.3 % +4.2 % View data
23 #23
Croatia
24,738,653.77 2019 +7.5 % +1.0 % View data
24 #24
Latvia
21,615,756.01 2019 +1.8 % +26.8 % View data
25 #25
Malta
5,841,633.29 2019 +431.6 % +35.2 % View data
Compare all 27 countries

Go Top